Alan P. Lyss
Impact in
-
- Pain Management and Opioid Use
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 31
- Cancer Treatment and Pharmacology 18
- Lung Cancer Research Studies 8
- HER2/EGFR in Cancer Research 5
-
- Lung Cancer Treatments and Mutations 12
- Lung Cancer Diagnosis and Treatment 5
- Advanced Breast Cancer Therapies 4
- Co-authors
- Douglas B. Cines (2 shared papers)Raphael J. DeHoratius (1 shared paper)James E. Herndon (10 shared papers)Joan H. Schiller (6 shared papers)Panos Fidias (4 shared papers)Coleman K. Obasaju (4 shared papers)Shaker R. Dakhil (4 shared papers)Joseph Treat (2 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Cancer (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Oncology Practice (3 papers)Clinical Lung Cancer (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Alan P. Lyss
65 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 110
- Anesthesiology and Pain Medicine 223
- Oncology 912
- Pulmonary and Respiratory Medicine 670
- Cancer Research 242
- Pediatrics, Perinatology and Child Health 194
Countries citing papers authored by Alan P. Lyss
This map shows the geographic impact of Alan P. Lyss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan P. Lyss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan P. Lyss more than expected).
Fields of papers citing papers by Alan P. Lyss
This network shows the impact of papers produced by Alan P. Lyss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan P. Lyss. The network helps show where Alan P. Lyss may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan P. Lyss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 303 | |
| 2 | 2020 | 207 | |
| 3 | 1984 | 204 | |
| 4 | Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. | 1991 | 193 |
| 5 | 1999 | 181 | |
| 6 | 2015 | 155 | |
| 7 | 1982 | 124 | |
| 8 | 2004 | 116 | |
| 9 | 2005 | 90 | |
| 10 | 2001 | 76 | |
| 11 | 1993 | 67 | |
| 12 | 2003 | 54 | |
| 13 | 1981 | 50 | |
| 14 | 2012 | 49 | |
| 15 | 2019 | 44 | |
| 16 | Appendiceal malignancies. | 1988 | 44 |
| 17 | 2009 | 42 | |
| 18 | 2010 | 41 | |
| 19 | Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642). | 1995 | 40 |
| 20 | 2012 | 35 |
About Alan P. Lyss
Alan P. Lyss is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 66 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (18 papers), Lung Cancer Treatments and Mutations (12 papers), Breast Cancer Treatment Studies (11 papers), Lung Cancer Research Studies (8 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Cancer therapeutics and mechanisms (5 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (223 citations), Oncology (912 citations), Pulmonary and Respiratory Medicine (670 citations), Cancer Research (242 citations) and Pediatrics, Perinatology and Child Health (194 citations). Alan P. Lyss has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Douglas B. Cines, Raphael J. DeHoratius, James E. Herndon, Joan H. Schiller, Panos Fidias, Coleman K. Obasaju, Shaker R. Dakhil, Joseph Treat, Mark R. Green and David Waterhouse. Their work appears in journals such as Journal of Clinical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics, Journal of Oncology Practice and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.